Prudential Financial
HRMY icon

Prudential Financial’s Harmony Biosciences HRMY Stock Holding History

Prudential Financial’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9M Sell
79,674
-2,200
-3% -$69.4K ﹤0.01% 1249
2026
Q1 		$2.29M Buy
81,874
+11,750
+17% +$385K ﹤0.01% 1261
2025
Q4 		$2.62M Buy
70,124
+11,958
+21% +$393K ﹤0.01% 1187
2025
Q3 		$1.6M Sell
58,166
-93,420
-62% -$3.22M ﹤0.01% 1459
2025
Q2 		$4.79M Buy
151,586
+47,803
+46% +$1.54M 0.01% 925
2025
Q1 		$3.44M Buy
103,783
+43,872
+73% +$1.57M ﹤0.01% 1018
2024
Q4 		$2.06M Buy
59,911
+28,650
+92% +$984K ﹤0.01% 1289
2024
Q3 		$1.25M Sell
31,261
-2,810
-8% -$98.7K ﹤0.01% 1767
2024
Q2 		$1.03M Sell
34,071
-3,000
-8% -$90.2K ﹤0.01% 1823
2024
Q1 		$1.24M Sell
37,071
-440
-1% -$14.1K ﹤0.01% 1715
2023
Q4 		$1.21M Sell
37,511
-29,231
-44% -$816K ﹤0.01% 1722
2023
Q3 		$2.19M Sell
66,742
-2,948
-4% -$102K ﹤0.01% 1315
2023
Q2 		$2.45M Buy
69,690
+13,011
+23% +$449K ﹤0.01% 1282
2023
Q1 		$1.85M Sell
56,679
-11,745
-17% -$535K ﹤0.01% 1390
2022
Q4 		$3.77M Buy
68,424
+347
+0.5% +$19.1K 0.01% 994
2022
Q3 		$3.02M Buy
68,077
+5,490
+9% +$268K 0.01% 1090
2022
Q2 		$3.05M Sell
62,587
-27,680
-31% -$1.25M ﹤0.01% 1150
2022
Q1 		$4.39M Buy
90,267
+66,112
+274% +$2.7M 0.01% 1044
2021
Q4 		$1.03M Buy
+24,155
New +$963K ﹤0.01% 1866

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prudential Financial's HRMY Position: Q2 2026 in Review

Prudential Financial reduced its Harmony Biosciences (HRMY) stake by 2.7% in Q2 2026, selling an estimated $69.4K and leaving 79,674 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1249.

Prudential Financial first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.79M in Q2 2025. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Prudential Financial held 79,674 shares of Harmony Biosciences worth $2.9M as of Q2 2026.
  • Prudential Financial sold 2,200 Harmony Biosciences shares in Q2 2026, an estimated $69.4K.
  • Harmony Biosciences made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1249 holding.
  • Prudential Financial first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Prudential Financial's Harmony Biosciences position peaked at $4.79M in Q2 2025.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.